Exercise and Ibuprofen May Help Mitigate Chemo Brain: New Research Outcomes

Cancer patients undergoing chemotherapy frequently encounter cognitive challenges known as “chemo brain,” marked by difficulties with focus, memory retention, and multitasking. Studies indicate approximately 80% of patients experience these cognitive impairments during treatment.

A recent Phase II clinical trial indicates that moderate exercise and low-dose ibuprofen administration could alleviate some of these cognitive difficulties. The research, published in CANCER—a peer-reviewed journal of the American Cancer Society—explores the therapeutic potential of these interventions.

Scientific Evaluation of Exercise and Ibuprofen

While physical activity and anti-inflammatory medications are recognized for supporting brain health in various conditions, their specific impact on chemotherapy-induced cognitive decline remains under investigation.

Researchers hypothesized that leveraging exercise and ibuprofen—two mechanisms targeting inflammation through distinct pathways—might offer synergistic cognitive protection during chemotherapy.

The trial involved 86 chemotherapy patients reporting cognitive symptoms, randomly assigned to four groups for six weeks: Exercise for Cancer Patients (EXCAP) combined with low-dose ibuprofen, EXCAP with placebo, ibuprofen alone, or placebo alone. EXCAP involved home-based, low-to-moderate intensity walking and resistance exercises.

Exercise Demonstrates Most Significant Cognitive Improvements

After six weeks, the EXCAP + Placebo group exhibited markedly better attention test results compared to the placebo group. Additionally, participants using ibuprofen only showed enhanced attention compared to placebo recipients.

Observational assessments by caregivers also noted reduced perceived cognitive issues in both EXCAP groups versus placebo, though ibuprofen alone showed less consistent results.

Notably, ibuprofen recipients exhibited poorer short-term verbal memory improvement than non-medicated participants, suggesting the need for further study in this area.

The data suggests exercise may serve as an effective strategy to maintain cognitive function during chemotherapy, while ibuprofen may offer targeted benefits in specific cognitive domains.

Future Research Imperatives

The research team emphasizes the necessity of larger Phase III trials to validate these findings and clarify optimal intervention protocols. Further exploration of exercise duration/dosage and ibuprofen dosing is required.

Dr. Michelle C. Janelsins, MD, MPH, from the University of Rochester and Wilmot Cancer Institute, highlighted, “This early-stage trial shows promising exercise-related benefits for several cognitive domains. Given exercise’s broader health advantages for cancer survivors, these results are particularly significant.” She stressed that individuals should consult healthcare providers before initiating any intervention to address cognitive impairments during treatment.

Source link